Apoptotic changes precede mitochondrial dysfunction in red cell-type pyruvate kinase mutant mouse erythroleukemia cell lines

Japanese Journal of Cancer Research

Volumn 90, Issue 2, 1999, Pages 171-179

  Aisaki, Ken Ichi ^a   Kanno, Hitoshi ^b   Oyaizu, Naoki ^a   Hara, Yukichi ^a   Miwa, Shiro ^b   Ikawa, Yoji ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b Okinaka Memorial Institute for Medical Research   (Japan)

Author keywords

Apoptosis; Cell lines; Friend erythroleukemia; Mitochondrial dysfunction; Pyruvate kinases

Indexed keywords

ADENOSINE TRIPHOSPHATE; LIPOCORTIN 5; PYRUVATE KINASE; RHODAMINE 123;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; DNA CONTENT; FEMALE; LEUKEMIA CELL LINE; MALE; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0033039561     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1999.tb00730.x     Document Type: Article

References (28)

1. Valentine, W. N., Tanaka, K. R. and Miwa, S. A specific erythrocyte glycolytic enzyme detect (pyruvate kinase) in three subjects with congenital non-spherocytic hemolytic anemia. Trans. Assoc. Am. Physicians. 74, 100-110 (1961).
2. Miwa, S., Kanno, H. and Fujii, H. Concise review: pyruvate kinase deficiency: historical perspective and recent progress of molecular genetics. Am. J. Hematol., 42, 31-35 (1993).
3. Tani, K., Yoshikubo, T., Ikebuchi, K., Takahashi, K., Tsuchiya, T., Tukahashi, S., Shimane, M., Ogura, H., Tojo, A., Ozawa, K. and Asano, S. Retrovirus-mediated gene transfer of human pyruvate kinase (PK) cDNA into murine hematopoietic cells: implications for gene therapy of human PK deficiency. Blood, 83, 2305-2310 (1994).
4. Morimoto, M., Kanno, H., Asai, H., Tsujimura, T., Fujii, H., Moriyama, Y., Kasugai, T., Hirono, A., Ohba, Y. and Miwa, S. Pruvate kinase deficiency of mice associated with nonspherocytic hemolytic anemia and cure of the anemia by marrow transplantation without host irradiation. Blood, 86, 4323-4330 (1995).
5. Kanno, H., Morimoto, M. Fujii, H., Tsujimura, T., Asai, H., Noguchi, T., Kitamura, Y. and Miwa, S. Primary structure of murine red blood cell-type pyruvate kinase (PK) and molecular characterization of PK deficiency identified in the CBA strain. Blood, 86, 3205-3210 (1995).
6. Imamura, K. and Tanaka, T. Multimolecular forms of pyruvate kinase from rat and other mammalian tissues. J. Biochem., 71, 1043-1051 (1972).
7. Nakashima, K., Miwa, S., Oda, S., Tanaka, T., Imamura, K. and Nishima, T. Electrophoretic and kinetic studies of mutnat erythrocyte pyruvate kinase. Blood, 43, 537-548 (1974).
8. Imamura, K., Tanaka, T., Nishina, T., Nakashima, K. and Miwa, S. Studies of pyruvate kinase (PK) deficiency. II. Electrophoretic, kinetic, and immunological studies of pyruvate kinase of erythrocytes and other tissues. J. Biochem., 74, 1165-1175 (1973).
9. Noguchi, T., Yamada, K., Inoue, H., Matsuda, T. and Tanaka, T. The L-and R-isozymes of rat pyruvate kinase are produced from a single gene by use of different promoters. J. Biol. Chem., 262, 14366-14371 (1987).
10. Kanno, H., Fujii, H. and Miwa, S. Structural analysis of human pyruvate kinase L-gene and identification of the promoter activity in erythroid cells. Biochem. Biophys. Res. Commun., 188, 516-523 (1992).
11. Takagawa, S., Fujii, H. and Miwa, S. Change of pyruvate kinase isozymes from M2-to L-type during development of the red cell. Br. J. Haematol., 54, 467-474 (1983).
12. Nijhof, W., Wierenga, P., Staal, G. and Jansen, G. Changes in activities and isozyme patterns of glycolytic enzymes during erythroid differentiation in vitro. Blood, 64, 607-613 (1984).
13. Max-Audit, I., Testa, U., Kechemir, D., Mithacila, M., Vainchenker, W. and Rosa, R. Pattern of pyruvate kinase isozymes in erythroleukemia cells lines and in normal human erythroblasts. Blood, 64, 930-936 (1984).
14. Noguchi, T., Inoue, H. and Tanaka, T. The M1-and M2-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing. J. Biol. Chem., 261, 13807-13812 (1986).
15. Ikawa, Y., Aida, M. and Inoue, Y. Isolation and characterization of high and low differentiation-inducible Friend leukemia lines. Gann, 67, 767-770 (1976).
16. Johnson, P., Chung, S. and Benchimol, S. Growth suppression of Friend virus-transformed erythroleukemia cells by p53 protein is accompanied by hemoglobin production and is sensitive to erythropoietin. Mol. Cell. Biol., 13, 1456-1463 (1993).
17. Darzynkiewicz, Z., Traganos, F., Staiano-Coico, L., Kapuscinski, J. and Melamed, M. R. Interactions of rhodamine 123 with living cells studied by flow cytometry. Cancer Res., 42, 799-806 (1982).
18. Bammel, B. P., Brand, J. A., Germon, W. and Smith, J. C. Interaction of the extrinsic potential-sensitive molecular probe diS-C3-(5) with pigeon heart mitochondria under equilibrium and time-resolved conditions. Arch. Biochem. Biophys., 244, 67-84 (1986).
19. Beutler, E., Blume, K., Kaplan, J., Löhr, G., Ramot, B. and Valentine, W. International committee for standardization in Haematology: recommended methods for red cell enzyme analyses. Br. J. Haematol., 35, 331-340 (1977).
20. Schröter, W. and Kalinowsky, W. Erythrocyte 2,3-diphosphoglycerate mutase: an optical test in hemolysates. Clin. Chim. Acta, 26, 283-285 (1969).
21. Tsujino, K., Kanno, H., Hashimoto, K., Fujii, H., Jippo, T., Morii, E., Lee, Y. M., Asai, H., Miwa, S. and Kitamura, Y. Delayed onset of hemolytic anemia in CBA-Pk-1slc/Pk-1slc mice with a point mutation of the gene encoding red blood cell type pyruvate kinase. Blood, 91, 2169-2174 (1998).
22. Morioka, K., Tone, S., Mukaida, M. and Takano-Ohmuro, H. The apoptotic and nonapoptotic nature of the terminal differentiation of erythroid cells. Exp. Cell Res., 240, 206-217 (1998).
23. Narita, H., Yanagawa, S., Sasaki, R. and Chiba, H. Induction of 2,3-bisphosphoglycerate synthase in Friend leukemia cells. Biochem. Biophys. Res. Commun., 103, 90-96 (1981).
24. Kim, H., Koury, M., Lee, S., Im, J. and Sawyer, S. Metabolic adaptation during erythropoietin-mediated terminal differentiation by mouse erythroid cells. Blood, 77, 387-392 (1991).
25. Vander-Heiden, M. G., Chandel, N. S., Williamson, E. K., Schumacker, P. T. and Thompsonm C. B. Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell, 91, 627-637 (1997).
26. Kluck, R. M., Bossy-Wetzel, E., Green, D. R. and Newmeyer, D. D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis, Science, 275, 1132-1136 (1997).
27. Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tomaselli, K. J., Debatin, K. M., Krammer, P. H. and Peter, M. H. Two CD95 (APO-1/Fas) signaling pathways. EMBO J., 17, 1675-1687 (1998).
28. Eguchi, Y., Shimizu, S. and Tsujimoto, Y. Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res., 57, 1835-1840 (1997).